In Kenya, the termination of the USAID-funded SMART4TB programme (2022-2025) halted significant research infrastructure and localized capacity building in TB diagnostics and treatment, leaving clinical trials incomplete and international collaborations severed.

Date: 10/25

Region: Africa

Country: Kenya

Topic: Health

Policy Lens: Global Health Security

Additional Context: The Supporting, Mobilizing, and Accelerating Research for Tuberculosis Elimination (SMART4TB) was a USAID-funded cooperative agreement that aimed to transform TB prevention and care. SMART4TB supported the design and implementation of TB-related research studies, working with local partners to identify effective person-centered methods for finding and treating TB. This program was terminated.

Source: Maurine Murenga, HIV expert